ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет Архив журнала 2000 год № 5-6

Профилактика и лечение индуцированного йодом тиреотоксикоза и его сердечно-сосудистых осложнений

John Т. Dunn (Отделение эндокринологии медицинского факультета университета Вирджинского Научного Центра Здравоохранения, Шарлоттесвиль, Вирджиния), MarcJ. Semigran (Кардиологическое отделение, Медицинский отдел, Массачусетский генеральный госпиталь, Гарвардская Медицинская школа, Бостон, Массачусетс), Francois Delange (ICCIDD , Брюссель, Бельгия.)
Данная статья является частью трудов Симпозиума по индуцированному йодом тиреотоксикозу, Бруклайн, МА, Март, 1996.
На русском языке статья впервые опубликована в 1999 году в сборнике "Преодоление последствий дефицита йода: зарубежный опыт" при поддержке детского фонда ООН (ЮНИСЕФ) под редакцией Г.А. Герасимова.
Публикуется с разрешения издателя

ЛИТЕРАТУРА

  1. Braverman LE, Uliger RD (eds). The Thyroid. A Fundamental and Clinical Text. 1996Lippincott-Raven, Philadelphia.
  2. Braverman LE. Iodine and the thyroid: 33 years of study. //Thyroid. – 1994 - 4: 351-356.
  3. Delange F. The disorders induced by iodine deficiency.// Thyroid. - 1994 - 4: 107-128.
  4. Delange F. Requirements of iodine in humans. In: Delange F, Dunn JT, Glinoer D (eds). Iodine Deficiency in Europe. A Continuing Concern. – 1993, Plenum Press, New York, pp. 5-13.
  5. Dremier S, Coppee F, Delange F, Vassart G, Dumont JK, Vansande J. Thyroid autonomy. Mechanism and clinical effects. // J CIin Endocrinol Metab - 1995 – 81 : 4187-4193.
  6. Bourdoux P, Thilly C, Delange C, Ermans AM A new look at old concepts in laboratory evaluation of endemic goiter. In: Ounn JT. Pretell EA, Daza СH, Viteri FE (eds), Towards the Eradication of Endemic Goiter, Cretinism, and Iodine deficiency. – 1986, Scientific Publication No. 502, Pan American Health Organisation, Washington, pp. 115-128.
  7. Delange F, Benker G, Caron Ph, Eber O, Ott W, Peter F, Podoba J, Simescu M. Szybinsky Z, Vertongen F, Vitti P, Wiersinga W, Zamrazil V. Thyroid volume and urinary iodine in European schoolchildren. Standardisation of values for assessment of iodine deficiency.// Eur J Endocrinol. – 1997- 136:180-187.
  8. Moulopoulos DS, Koutras DA, Mantzos J, Souvatzoglou A, Piperingos GD, Karaiskos KS, Makriyannis D, Sfontouris J, Moulopoulos SD. The relation of serum T4 and TSH with the urinary iodine excretion. // J Endocrinol Invest – 1988 - 11:437-439.
  9. Buchinger W, Lorenz-Wawschinek O, Binter G, Langsteger W, Bonelli R, Eber O. Relation between serum thyrotropin and thyroglobulin with urinary iodine excretion. In: Nauman J. Glinoer D. Braverman LE, Hostalek U (eds). The Thyroid and Iodine. - 1996, Schattauer. Stuttgart Germany, pp. 189-190.
  10. WHO/UNICEF/ICCIDD Recommended iodine levels in salt and guidelines for monitoring their adequacy and effectiveness. – 1996, Nutrition Unit, World Health Organisation, Geneva.
  11. Dai G, Levy O, Carrasco N. Cloning and characterisation of the Thyroid iodide transporter. // Nature - 1996. - 379:458-460.
  12. Phillipson KD, Edelman IE. Thyroid hormone control of Na/K-ATPase and K-dependent phosphatase in rat heart. // Am J Physics. – 1977 - 232: C 196 - C 201.
  13. Buccino RA., Spann JF Jr, Pool PE, Sonnenblick EH, Braunwald E. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. // J Clin Invest. – 1967 – 46 : 1669-1682.
  14. Josephson RA, Spurgeon HA, I.akatta EG. The hyperthyroid heart. An analysis of systolic and diastolic properties in single rat ventricular myocytes.// Circ Res - 1990 - 66:773-781.
  15. Alpert NR, Mulieri LA, Litten RZ. Functional significance of altered adenosine triphiosphatase activity in enlarged hearts. // Am J Cardiol. - 1979 – 44 : 947-953.
  16. Litten RZ, Martin BJ, Howe ER, Alpert NR, Solaro RJ. Phiosphorylation and adenosine triphosphatase activity of myofibrils from thyrotoxic rabbit hearts. // Circ Res. – 1981 - 48:498-501.
  17. Goto Y, Slinker BK, LeWinter MM. Decreased contractile efficiency and increased nonmechanical energy cost in hyperthyroid rabbit heart. // Circ Res. - 1990 - 66:999-1011.
  18. Mintz G, Pizzarello R. Klein I. Enhanced left ventricular diastolic function in hyperthyroidism: Non-invasive assessment and response to treatment. // J Clin Endocrinol Metab. – 1991. - 73:146-150.
  19. Hartong R, Wang N, Kurokawa R, Lazar MA, Glass CK, Apriletti JW, Dillmann WH. Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca-AT-Pase gene.// J Biol Chem 1994 - 269:13021 -9.
  20. Martin WH, Spina RJ, Korte E. Effect of hyperthyroidism of short duration on cardiac sensitivity to beta-adrenergic stimulation. // Am Coil Cardiol. - 1992 - 19:1185-91.
  21. Proskey AJ, Saksena F, Towne WD. Myocardial infarction associated with thyrotoxicosis. // Chest. – 1977 - 72:109-112.
  22. Fazio S, Biondi B, Carella C, Sabatini D, Cittadini A, Panza N, Lombardi G, Sacca L. Diastolic dysfunction in patients on thyroid stimulating hormone suppressive therapy with levothyroxine: Beneficial effect of beta-blockade. // J Clin Endocrinol Metab. – 1995 – 80 : 2222-2226.
  23. Sawin СТ. Geller A, Wolf PA, Belanger AJ, Baker E, Bacharacli P, Wilson PW, Benjamin EJ, D'Agostiho RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. // N Engl. J Med. – 1994 - 331: 1244-1252.
  24. Forfar JC, Muir AL, Sawers SA, Toft AD. Abnormal left ventricular function in hyperthyroidism. Evidence for a possible reversible cardiomyopathy. // N Engl. J Med. – 1982 - 307; 1165-1170.
  25. Umpierrez GE. Challapalli S, Patterson С. Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism. // Am J Med Sci. – 1995. - 310:99-102.
  26. Johnson RN, Freedberg AS, Marshall JM. Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle in cells isolated atria of rabbits. // Cardiology – 1973 - 58:273-289.
  27. Arnsdort MF, Chllders RW. Atrial eleclrophysiology in experimental hyperthyroidism in rabbits.// Circ Res. – 1970 - 26:575-581.
  28. Presti CF, Hart RG. Thyrotoxicosis, atrial fibrillation, and embolism, revisited. // Am Heart J. – 1989. - 117:976-977.
  29. Staffurth JA, Gibberd MC, Fui SNT. Arterial embolism in thyrotoxicosis with atrial fibrillation. // BMJ – 1977 - 2:688-690.
  30. Nakazawa HK, Handa S, Nakamura Y. Oyanagi H, Hasegawa M. Ishikawa N, Ozaki O, Ito К. High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.// Int J Cardiol. – 1987 - 16:47-55.
  31. Yuen RW, Gutteridge DH, Thompson PL, Robinson JS. Embolism in thyrotoxic atrial fibrillation. // Med J Aust. – 1979. - 13:630-631.
  32. Hurley DM, Hunter AN, Hewctt MJ, Stocking JR. Atrial fibrillation and arterial embolism in hyperthyroidism. // Aust N Z J Med. – 1981 - 11:391-393.
  33. Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. // Arch Intern Med. – 1981 - 141:1191-1192.
  34. Corvilain В, Van Sande J, Dumont JE, Bourdoux P, Ermans AM. Autonomy in endemic goiter. // Thyroid. – 1997 - 8:107-113.
  35. WHO. UNICEF. International Council for the Control of Iodine Deficiency Disorders Indicators iodine deficiency disorders and their control through salt iodination. – 1994, WHO, Geneva.
  36. ICCIDD. Guideline for assessment of progress towards IDD elimination.// IDD Newsletter. – 1996 - 12(4):64.

Для специалистов

Новостная рассылка

Поиск